Transverse Myelitis in Veterans: Epidemiology and Outcomes (P6.129)

Conclusions: This is the first comprehensive characterization of TM in the VHA Veteran population. Patients with TM within the VHA system provide a population for long-term evaluation of disease characteristics and response to treatment. Within this cohort, diverse etiologies lead to TM involvement of 3 or more spinal cord levels, indicating low sensitivity for neuromyelitis optica.Disclosure: Dr. Carlson has nothing to disclose. Dr. Haringer has nothing to disclose. Dr. Sweeney has nothing to disclose. Dr. Rose has received research support from Biogen Idec, AbbieVie Biotherapeutics, Teva, Cumming Foundation, National Multiple Sclerosis Society, VA and NIH. Dr. Carlson has nothing to disclose. Dr. Greenlee has received royalty payments from MedLink and Merck. Dr. Paz Soldan has nothing to disclose. Dr. Clardy has received personal compensation for activities with the DAVICK Group and Trinity Partners. Dr. Clardy's spouse holds stock and/or stock options in Quadex. Dr. Clardy has received research support from Western Institue for Biomedical Research

Source: Neurology - April 3, 2016 Category: Neurology Authors: Carlson, H., Haringer, V., Sweeney, M., Rose, J., Carlson, N., Greenlee, J., Paz Soldan, M., Clardy, S. Tags: MS and CNS Inflammatory Disease: CNS Inflammatory Diseases and Differential Diagnosis Source Type: research